Cardiac-Safe Ibogaine
The Most Psychologically Resilient Force on Earth.
Aurablis is developing a cardiac-safe ibogaine: a medicine with decades of human signal against PTSD and addiction, engineered for the heart, and built to reach every service member, veteran, and American who needs it.
Our mission
To build the most psychologically resilient fighting force on the planet, and to carry that resilience home to every American community.
Readiness, Protected
Reach post-traumatic stress and addiction before they end careers or lives.
Healing That Comes Home
A treatment veterans no longer have to cross a border, or risk their hearts, to receive.
Resilience, at Scale
The same medicine for the civilians and communities the force is drawn from.
The crisis
America’s Deadliest Threat: Mental Health.
Since 9/11, Suicide Has Taken Four Times as Many Lives as Combat.
Every Month, Overdose Kills Nearly Twice the Toll of 9/11.
Veterans Aren’t Failing Treatment. Treatment Is Failing Veterans.
Sources: Costs of War Project, Brown University (2021); CDC/NCHS; JAMA (2015); VA trial and outpatient data.
The signal
Stanford: One Ibogaine Treatment Cut Veterans’ PTSD Symptoms by 88%.
Thirty U.S. special-operations veterans with traumatic brain injury, one month after a single treatment (Nature Medicine, 2024).
The Catch
It was given in Mexico, with intravenous magnesium and continuous cardiac monitoring. Today, veterans pay $10,000 or more in cash for a 24-hour psychedelic experience on a heart monitor.
Our approach
The Medicine Works. We’re Solving the Heart of the Problem.
At standard doses, ibogaine can disrupt the heart’s rhythm, which is why it lives in clinics, under monitors, often abroad, and why it remains unapproved in the United States. Others manage the patient or change the molecule. We keep the molecule and apply proprietary drug-delivery science to address its cardiac risk.
The Same Molecule
Ibogaine itself, not an analog: the compound behind decades of human signal.
Engineered for the Heart
Proprietary delivery science designed to address the cardiac risk that has kept ibogaine out of American medicine.
Built to Scale
From what a clinic can supervise to what a health system can prescribe.
Why us
We’ve Done This Before: Turned Hard Molecules Into Products the Market Trusts.
Our team has spent years making complex plant-derived compounds deliverable, consistent, and commercially proven. We pair rigorous science with the regulatory and commercial know-how to bring ibogaine into mainstream medicine.
Why now
Two Years Ago, Ibogaine Was Untouchable. Today, Washington Is Moving It Toward Approval.
- FY2024Congress authorizes Department of Defense psychedelic research, ibogaine included.
- 2025Texas commits $50 million to ibogaine clinical research, the strongest state signal yet.
- April 2026Executive Order 14401 names ibogaine, opens Right to Try, and fast-tracks breakthrough psychedelics.
- 2026The bipartisan IBOGAINE Act is introduced; VA and HHS expand psychedelic research.
Executive orders can be reversed. National security outlasts administrations.
The contested domain
Our Adversaries Treat the Mind as a Battlefield. We Treat It as a Capability to Defend.
Suicide, post-traumatic stress, and opioid addiction are among the most damaging forces acting on American military readiness. A medicine that can reach service members and veterans at scale is more than a healthcare advance. It is a readiness capability.
Healing is readiness.
Pipeline
One Dataset, Two Programs.
First human cardiac-safety data targeted for 2027.
Join the Mission.
Service members who shouldn’t have to choose between a career and getting well. Veterans who shouldn’t need a passport to heal. Families that shouldn’t lose one more person to an overdose.
This is why Aurablis exists.
Contact
Whether you serve, run research, or shape policy, we’d welcome the conversation.
Investing in the future of healing? Request access to our private investor portal.